Sandra Maria Blois

Prof. Dr. Sandra Maria Blois

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2007 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
SBSandra Maria Blois
Sandra Maria Blois
JIJuan M Ilarregui
Juan M Ilarregui
MTMareike Tometten
Mareike Tometten
MGMariana Garcia
Mariana Garcia
AOArif S Orsal
Arif S Orsal
PAPetra C Arck
Petra C Arck

1 January 2008 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
PAPetra C Arck
Petra C Arck
MRMirjam Rücke
Mirjam Rücke
MRMatthias Rose
Matthias Rose
JSJulia Szekeres-Bartho
Julia Szekeres-Bartho
ADAlison J Douglas
Alison J Douglas
BKBurghard F Klapp
Burghard F Klapp

1 October 2007 in Biology of Reproduction
Verified
Journal Article
Open access
PDF file
SBSandra Maria Blois
Sandra Maria Blois
UKUlrike Kammerer
Ulrike Kammerer
CSCatalina Alba Soto
Catalina Alba Soto
MTMareike C. Tometten
Mareike C. Tometten
VSValerie Shaikly
Valerie Shaikly
PAPetra C. Arck
Petra C. Arck
Pregnancy is a unique event in which a fetus, despite being genetically and immunologically different from the mother (a hemi-allograft), develops in

1 April 2004 in Biology of Reproduction
Verified
Journal Article
Closed access
PDF file
SBSandra Maria Blois
Sandra Maria Blois
CSCatalina D. Alba Soto
Catalina D. Alba Soto
MTMareike Tometten
Mareike Tometten
BKBurghard F. Klapp
Burghard F. Klapp
RMRicardo A. Margni
Ricardo A. Margni
PAPetra C. Arck
Petra C. Arck
Dendritic cells (DCs) are known to play a major role in the induction, maintenance, and regulation of immune responses. Recently, DCs have been described to be present at the feto-maternal interface in human decidua. However, only limited information is available about DC presence, phenotype, and—more importantly—function throughout gestation. Thus, we analyzed local (uterine) and systemic (blood) DCs in a murine model. DBA/2J mated CBA/J females with vaginal plugs were separated and killed on Gestation Days (GDs) 1.5, 3.5, 5.5, 6.5, 7.5, 8.5, 10.5, 13.5, 15.5, or 17.5. Frequency of uterine and blood CD11c+ DC, phenotype (coexpression of CD8α and major histocompatibility complex class II [MHC II] antigens), and presence of intracellular cytokines (interleukins 12 and 10) were determined by flow cytometry. The morphology of DC in the pregnant uterus was evaluated by immunohistochemistry. In uterus, the relative number of CD11c+ cells increased from GD 5.5, reaching a plateau on GD 9.5 until GD 17.5, while a transient peak of systemic CD11c+ cells was found on GD 8.5 and 10.5. The vast majority of uterine DCs were CD8α− and thus, belonged to the myeloid lineage. Interestingly, a significant peak of lymphoid DC was present on GD 1.5 and 5.5. Further, significantly more intracellular interleukin 10 than interleukin 12 was present in CD11c+ cells. Interestingly, mature DCs (MHC II+) were diminished from GD 5.5 to 8.5. Characterization of CD11c+ cell kinetics in uterus and blood reveals variation of phenotype during pregnancy, pointing toward an eminent immunoregulatory role of DCs throughout gestation at the feto-maternal interface.

15 May 2004 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SBSandra Maria Blois
Sandra Maria Blois
RJRicarda Joachim
Ricarda Joachim
JKJudith Kandil
Judith Kandil
RMRicardo Margni
Ricardo Margni
MTMareike Tometten
Mareike Tometten
PAPetra C. Arck
Petra C. Arck
One of the most remarkable immunological regulations is the maternal immune tolerance toward the fetal semiallograft during pregnancy, which has been referred to as immunity’s pregnant pause. Rejection of the semiallogeneic trophoblast cells must be selectively inhibited and pathways presumably include Th2 cytokines unopposed by Th1 cytokines. Steroid hormones, including progesterone, have similar effects. Low levels of progesterone and Th2 cytokines and high levels of Th1 cytokines are attributable for increased abortions in mammalians, which may be triggered by psychoemotional stress. Thus, the aim of the present study was to provide experimental evidence for the mechanism involved in the mediation of immune responses by endocrine signals during pregnancy and stress-triggered pregnancy failure. DBA/2J-mated CBA/J female mice were randomized in three groups: 1) control females, 2) mice exposed to stress on gestation day 5.5, and 3) mice exposed to stress and substituted with dydrogesterone, a progestogen with a binding profile highly selective for the progesterone receptor on gestation day 5.5. On gestation days 7.5, 9.5, and 10.5, mice of each group were sacrificed, and the frequency of CD8+ cells and cytokine expression (IL-4, IL-12, TNF-α, IFN-γ) in blood and uterus cells was evaluated by flow cytometry. Additionally, some mice were depleted of CD8 cells by injection of mAb. We observed that progesterone substitution abrogated the abortogenic effects of stress exposure by decreasing the frequency of abortogenic cytokines. This pathway was exceedingly CD8-dependent, because depletion of CD8 led to a termination of the pregnancy protective effect of progesterone substitution.

1 March 2011 in Journal of Reproductive Immunology
Verified
Journal Article
Closed access
SBSandra Maria Blois
Sandra Maria Blois
BKBurghard F. Klapp
Burghard F. Klapp
GBGabriela Barrientos
Gabriela Barrientos